Back
Teleflex Incorporated (TFX)
Health CareTFX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$133.54
−0.58%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-20.30
ROE
0.0%
Gross margin
55.3%
Debt/Equity
0.89x
Revenue growth
32.3%
Teleflex Incorporated — company intelligence
Earnings surprises
Q1 2026$1.39 vs $1.22 est+14.1%
Q4 2025$1.93 vs $3.77 est-48.8%
Q3 2025$3.67 vs $3.42 est+7.4%
Q3 2000$0.55 vs $0.56 est-1.3%
Analyst consensus · 17 analysts
6 Buy11 Hold0 Sell
Updated Jul 4, 2026
Insider activity · 90 days
17 buys2 sellsnet +106,879 shares
RANDLE STUART ABuy 995 · Jun 8, 2026
Weidman Jason R.Buy 53,983 · Jun 8, 2026
Weidman Jason R.Buy 26,071 · Jun 8, 2026
Recent SEC filings
8-K — Material event reportJun 15, 2026
4 — Insider transaction reportJun 9, 2026
4 — Insider transaction reportJun 9, 2026
Latest news
Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold — Benzinga · 2w ago
Teleflex Presents 4‑Yr Follow‑Up Data From First-in-Human BIOMAG-I Clinical Study At EuroPCR Conference — Benzinga · Jun 9, 2026
Piper Sandler Upgrades Teleflex (TFX) — Fintel · Jun 9, 2026
Piper Sandler Upgrades Teleflex to Overweight, Raises Price Target to $160 — Benzinga · Jun 8, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Teleflex Incorporated
Weekly undervalued picks (like TFX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.